Novartis Investigative Site
Libramont 6800
0 studies enrolling now · 5 studies all time
What they study most
Breast Cancer, Early Breast Cancer, Non-small Cell Lung Cancer, Ovarian Cancer
Studies at this site
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
- Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. — Completed
- Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
- Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer — Completed
- Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer — Completed